95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.44%
Revenue growth under 50% of NEM's 17.10%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.52%
Negative gross profit growth while NEM is at 26.41%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.37%
Positive EBIT growth while NEM is negative. John Neff might see a substantial edge in operational management.
3.37%
Positive operating income growth while NEM is negative. John Neff might view this as a competitive edge in operations.
116.27%
Positive net income growth while NEM is negative. John Neff might see a big relative performance advantage.
116.67%
Positive EPS growth while NEM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
116.67%
Positive diluted EPS growth while NEM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.06%
Maintaining or increasing dividends while NEM cut them. John Neff might see a strong edge in shareholder returns.
-2.98%
Negative OCF growth while NEM is at 13.55%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-154.52%
Negative FCF growth while NEM is at 15.01%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
13.83%
Positive 10Y revenue/share CAGR while NEM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
5.51%
5Y revenue/share CAGR under 50% of NEM's 26.14%. Michael Burry would suspect a significant competitive gap or product weakness.
39.64%
3Y revenue/share CAGR above 1.5x NEM's 10.98%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-6.33%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
9.59%
Below 50% of NEM's 36.61%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
77.68%
3Y OCF/share CAGR above 1.5x NEM's 17.69%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
58.27%
Net income/share CAGR at 50-75% of NEM's 97.22%. Martin Whitman might question if the firm’s product or cost base lags behind.
2532.91%
5Y net income/share CAGR above 1.5x NEM's 91.10%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
4117.56%
Positive short-term CAGR while NEM is negative. John Neff would see a clear advantage in near-term profit trajectory.
84.86%
10Y equity/share CAGR above 1.5x NEM's 6.11%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
24.04%
5Y equity/share CAGR at 50-75% of NEM's 36.74%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
19.25%
Below 50% of NEM's 40.59%. Michael Burry suspects a serious short-term disadvantage in building book value.
41.31%
Stable or rising dividend while NEM is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
147.79%
Below 50% of NEM's 1016.33%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
64.03%
Below 50% of NEM's 289.75%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
7.97%
AR growth well above NEM's 0.90%. Michael Burry fears inflated revenue or higher default risk in the near future.
42.63%
We show growth while NEM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
4.12%
Asset growth above 1.5x NEM's 1.75%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.09%
Positive BV/share change while NEM is negative. John Neff sees a clear edge over a competitor losing equity.
-6.08%
We’re deleveraging while NEM stands at 0.96%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
16.95%
SG&A growth well above NEM's 13.11%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.